Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy.
Roberto MapelliChiara JulitaSofia Paola BianchiNicolò GallinaRaffaella LucchiniMartina MidullaFlavia PuciJessica SaddiSara TrivellatoDenis PanizzaElena De PontiStefano ArcangeliPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)
Although iatrogenic immunosuppression could be associated with inferior clinical outcomes, our data show that treatment-related lymphopenia does not adversely affect GBM survival. Prospective studies are required to confirm these findings.